摘要
众所周知,包括溃疡性结肠和卡罗恩疾病在内的炎症肠道疾病(IBD)是结肠直肠癌(CRC)的高危因素之一。这支持了炎症在癌症发展中发挥关键作用的观念。流行病学研究显示维生素D(Vit D)缺乏与IBD以及各种类型包括结肠癌在内的癌症有关。临床试验和小鼠模型显示维生素D有助于预防和改善炎症和致癌作用。机制研究表明维生素D在抗炎、免疫调节、抗癌作用中发挥广泛的作用。本文我们对维生素D、IBD和结肠直肠癌以及维生素D对抗炎、EMT以及癌症干细胞的影响最近的研究进行了综述。
关键词: 维生素D, IBD, 结肠相关的结肠癌,炎症,NF-kB
Current Medicinal Chemistry
Title:Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer
Volume: 24 Issue: 9
关键词: 维生素D, IBD, 结肠相关的结肠癌,炎症,NF-kB
摘要: It is well accepted that inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, is one of high risk factors for colorectal cancer (CRC). This supports the notion that inflammation plays a key role in cancer development. Epidemiologic studies have shown that vitamin D (Vit D) deficiency is associated with IBD and various types of cancer including colorectal cancer. Clinical trials and mouse models have shown that Vit D is beneficial in preventing or ameliorating inflammation and carcinogenesis. Mechanism studies show that Vit D played wide-spectrum roles in anti-inflammation, immunoregulation, and anti-cancer activities. In this review, we summarized and updated the findings on Vit D, IBD and colitis-associated colorectal cancer (CAC) with the emphasis on the effects of Vit D on anti-inflammation, EMT and cancer stem cells (CSC).
Export Options
About this article
Cite this article as:
Possible Molecular Mechanisms by which Vitamin D Prevents Inflammatory Bowel Disease and Colitis-associated Colorectal Cancer, Current Medicinal Chemistry 2017; 24 (9) . https://dx.doi.org/10.2174/0929867323666161202153028
DOI https://dx.doi.org/10.2174/0929867323666161202153028 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
SnoN: Bridging Neurobiology and Cancer Biology
Current Molecular Medicine Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Current Cancer Drug Targets Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Current Pharmaceutical Design Breast Cancer: A Review of Risk Factors and New Insights into Treatment
Current Cancer Therapy Reviews Role of Integrated 18-F FDG PET/CT in Recurrent Ovarian Cancer
Current Medical Imaging The Role of Dietary Approach in Irritable Bowel Syndrome
Current Medicinal Chemistry APE1/Ref-1Role in Redox Signaling: Translational Applications of Targeting the Redox Function of the DNA Repair/Redox Protein APE1/Ref-1
Current Molecular Pharmacology PET Tracers Based on Zirconium-89
Current Radiopharmaceuticals Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
Current Cancer Drug Targets An Integrated Metabolomics and Pharmacokinetics Strategy for Multi-Component Drugs Evaluation
Current Drug Metabolism microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer
Current Pharmaceutical Design Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy
Current Genomics The Weal and Woe of Costimulation in the Adoptive Therapy of Cancer with Chimeric Antigen Receptor (CAR)-Redirected T Cells
Current Molecular Medicine Editorial (Thematic Issue: Perspectives on Strategies for Overcoming Cancer Therapy Resistance)
Current Protein & Peptide Science Pharmacophore Generation and 3D-QSAR of Novel 2-(quinazolin-4- ylamino)-[1,4] Benzoquinone Derivatives as VEGFR-2 Inhibitors
Letters in Drug Design & Discovery Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy
Current Drug Targets CRH Receptor Signalling: Potential Roles in Pathophysiology
Current Molecular Pharmacology HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab
Current Cancer Drug Targets The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets